University of Pittsburgh Cancer Institute (UPCI)

CCSG Acknowledgement

Required CCSG Acknowledgement

The NCI requires that publications acknowledge the UPCI CCSG support, and they are tracking compliance. If a UPCI CCSG-supported Shared Facility provided data used in your publication, please include the following statement in the acknowledgment section of your publication(s):

"This project used the UPCI [insert name(s) of shared facility(ies)] that [is/are] supported in part by award P30CA047904."

Shared Facility Directors: Please make sure to include this statement on all of your order forms, contracts, etc. as a reminder to your users to acknowledge the UPCI CCSG support.


Overview

Novel Chemistries and Systems Biology

The UPCI Chemical Biology Facility (ChBF) has emerged from an innovative UPCI-supported pilot project to become a Shared Facility, applying state-of-the-art resources of the University of Pittsburgh Drug Discovery Institute to cancer-related research problems. The overall goal of the ChBF is to ensure that UPCI members have access to the most modern chemical biology reagents, instrumentation, and personnel, which will enable them to identify unique chemical probes and potential anticancer leads for further optimization. The ChBF also promotes the development and implementation of innovative cancer-related assays at UPCI, such as novel HCS assays focused on targets that have traditionally been considered "undruggable."

Read more about ChBF collaborative research projects that are focused on understanding cancer and identifying novel therapeutic agents and approaches to discovery and development.